Page 5 - Karya dan Kinerja Melewati Multi Krisis: Pandemi COVID-19

Karya dan Kinerja
Melewati Multi Krisis:
Pandemi COVID-19

BAB 2 ..........................................................................................................85
Berjibaku Menemukan Obat dan Vaksin COVID-19 serta
Mengawal Vaksin Anak Bangsa .......................................................... 86
2.1. Kerja Keras Mencari Vaksin COVID-19 .............................................. 88
2.1.1. Mendatangkan Vaksin COVID-19 Pertama di Indonesia ...... 88
2.1.2. Benchmarking Uji Klinik Vaksin Sinopharm
di Persatuan Emirat Arab (PEA) ............................................100
2.1.3. Pencarian Data Mutu Vaksin ke Rusia dan Hungaria ........... 101
2.1.4. Menjadi Pionir Terbitkan Persetujuan Vaksin COVID-19 ....102
2.1.5. Persingkat Registrasi Demi Memberantas COVID-19 .........104
2.2. Menuju Kemandirian Vaksin COVID-19 ..........................................105
2.2.1. Penelitian dan Pengembangan Vaksin COVID-19
Dalam Negeri ...........................................................................106
2.2.1.1 Vaksin Indovac ..............................................................107
2.2.1.2 Vaksin Merah Putih: Inavac ........................................113
2.2.2 Mengawal Transfer Teknologi Vaksin Pengembangan
Luar Negeri ...............................................................................123
2.2.2.1 InaRNAVac ...................................................................123
2.2.2.2 Zifivax ...........................................................................126
2.3. Upaya Mencari Obat COVID-19 .......................................................127
2.4. Tidak Semua Pengembangan Menghasilkan Produk
yang Dapat Diedarkan ........................................................................131
2.4.1 Obat Kombinasi UNAIR ...........................................................131
2.4.2 Vaksin Berbasis Sel Dendritik .................................................132
2.4.3 Ivermectin .................................................................................135
2.4.4 Vaksin Genexine (GX-19N) .....................................................137
2.5. Keberhasilan Vaksinasi COVID-19 ....................................................138
2.6. Percepatan dan Pengawasan Importasi
Obat dan Vaksin COVID-19 ...............................................................142
2.7. Kolaborasi dan Kredibilitas Internasional untuk Produk Obat
Aman dan Berdaya Saing ...................................................................144
2.7.1. Kerja Sama Bilateral dan Multilateral ....................................148
2.7.1.1. Pengakuan World Health Organization (WHO) .......148
2.7.1.2. Kerja Sama Negara OKI ..............................................150
2.7.1.3. Therapeutic Goods Administration (TGA) Australia ...151
2.7.1.4. Indo Pacific Regulatory Strengthening Program
Virtual Steering Forum (RSP Forum)........................152
2.7.1.5. Regional Vaccine Advisory Group (RVAG) ...............153
2.7.2. Inisiatif Kerja Sama Internasional ..........................................154
2.7.2.1. Kunjungan Ministry of Health and Prevention
(MOHAP) Persatuan Emirat Arab (PEA) ..................154

iv